drugset / Trial / NCT01517802
A Study That Provides Long-term Safety Follow-up and Examines Long-term Exposure to Abiraterone Acetate
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to collect follow-up safety data from participants in completed abiraterone acetate studies for a maximum duration of 9 years.
Timeline
- Start
- 2012-03-28
- Primary completion
- 2021-04-22
- Completion
- 2021-04-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Abiraterone acetate | Small molecule | 1000 mg | Oral |
| Background | Prednisone | Other / unclassified | 5 mg | Oral |